Sanofi-Aventis, the French drug manufacturer, said on 18 June that it was planning to make a counterbid of $2.57bn for the shares in Zentiva, the Czech pharma firm, that it does not already own.
39987
Sanofi-Aventis makes counterbid for Zentiva
79889
Merck buys drug rival Schering-Plough
70332
Merck to buy insulin developer
136747
Pfizer to buy Wyeth for $68 billion;
112080
Solutia initiates stock offering
5493
Dufenergy may sell Italian commercial arm
66069
Targacept publicly offering 2.2 million shares
85203
Sanofi to shed 900 jobs in France
143789
Gentiva sells respiratory, infusion businesses
29024
Lancelot Investment accused of aiding Ponzi scheme
100390
Teva Pharmaceutical launches generic Yaz
112856
Drug company paying nh $1.2 million
17041
Pfizer to pay $68 billion for Wyeth
33271
``Companies at liberty to increase drug prices in relation to the dollar''
36114
European Commission approves labelling update for REYATAZ® (atazanavir sulfate) in pregnant women living with HIV
92657
Roche boosts offer for Genentech
24301
Pfizer to acquire rival Wyeth for $68bn